Nautilus Biotechnology reported cash from operations of -$13.73M and free cash flow of -$14.18M for the quarter ended Jun 2026, down 2.8% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||
| Net Income | -15.03M | -14.46M | ||||||||||||||||||||||
| Share-based Compensation | 2.25M | 24.49M | 2.11M | 2.57M | 2.87M | 2.83M | 7.62M | 1.44M | 3.07M | 3.11M | 3.28M | 3.18M | 3.12M | 2.17M | 1.71M | 1.50M | 1.47M | 1.36M | 1.16M | |||||
| Cash from Operations | -14.18M | -10.52M | -12.34M | -13.53M | -9.56M | -10.38M | -12.52M | -13.55M | -11.74M | -13.90M | -16.27M | -15.46M | -13.11M | -14.31M | -13.94M | -13.35M | -11.03M | -12.38M | -13.10M | -13.73M | ||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.46M | 0.61M | 0.53M | 0.55M | 0.55M | 0.57M | 0.79M | 1.02M | 1.01M | 1.03M | 1.07M | 1.08M | 1.10M | 1.12M | 1.16M | 1.18M | 1.19M | 4.20M | 1.14M | 1.01M | ||||
| Change in Working Capital | ||||||||||||||||||||||||
| Change in Account Payables | 0.16M | 0.37M | -0.39M | -0.25M | -0.21M | 0.29M | 0.05M | -0.25M | 0.22M | 0.37M | 0.09M | -0.40M | 0.27M | -0.54M | -0.13M | 0.08M | -0.02M | 0.00M | 0.20M | -0.30M | ||||
| Change in Accured Expenses | 1.12M | 0.72M | 0.31M | -0.32M | 0.87M | -0.45M | 0.07M | -0.18M | 0.87M | -0.34M | -0.27M | -0.44M | -0.02M | -0.67M | 0.53M | -0.14M | 0.94M | -0.70M | 0.13M | 0.25M | ||||
| Other Working Capital Changes | 4.70M | -1.11M | -0.55M | 1.06M | -1.37M | -0.53M | -0.53M | -0.85M | -0.82M | -1.01M | -1.01M | -1.02M | -1.03M | -1.09M | -1.14M | -1.16M | -1.18M | 4.20M | -1.15M | -1.06M | ||||
| Investing Activities | ||||||||||||||||||||||||
| Capital Expenditures | 0.27M | 0.99M | 0.48M | 0.65M | 0.96M | 0.23M | 0.69M | 0.46M | 0.87M | 0.41M | 0.65M | 0.51M | 0.71M | 0.25M | 0.22M | 0.40M | 0.42M | 0.24M | 0.51M | 0.45M | ||||
| Change in Acquisitions & Divestments | 45.10M | 38.58M | 67.00M | 36.50M | 21.10M | 14.25M | 18.00M | 19.00M | 20.35M | 23.00M | 30.50M | 36.91M | 65.00M | 26.63M | 19.25M | 28.36M | 34.75M | 25.80M | 29.91M | |||||
| Cash from Investing Activities | -83.98M | 6.06M | 15.18M | 35.08M | -11.94M | -64.06M | -13.49M | -2.25M | 13.07M | -41.06M | 22.35M | 14.29M | -7.50M | 37.11M | 19.51M | 14.47M | 0.45M | 0.79M | 14.23M | 12.02M | ||||
| Financing Activities | ||||||||||||||||||||||||
| Other financing activities | 0.06M | 0.06M | 0.16M | 0.03M | 0.09M | 0.06M | 0.00M | 0.09M | 0.17M | 0.24M | 0.04M | 0.13M | 0.20M | 0.02M | 0.07M | 0.07M | 1.10M | 0.10M | ||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||
| Long-Term Debt Issuances | ||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||
| Cash from Financing Activities | 0.01M | 0.06M | 0.16M | 0.18M | 0.09M | 0.14M | 0.00M | 0.10M | 0.02M | 0.25M | 0.24M | 0.32M | 0.14M | 0.44M | 0.02M | 0.10M | 0.10M | 1.10M | 0.24M | |||||
| Change in Cash | -98.15M | -4.39M | 3.00M | 21.73M | -21.42M | -74.30M | -26.02M | -15.71M | 1.35M | -54.71M | 6.33M | -0.84M | -20.48M | 23.24M | 5.59M | 1.22M | -10.58M | -11.49M | 2.24M | -1.46M | ||||
| Free Cash Flow | -14.45M | -11.51M | -12.82M | -14.18M | -10.53M | -10.61M | -13.22M | -14.01M | -12.61M | -14.31M | -16.91M | -15.97M | -13.82M | -14.56M | -14.16M | -13.75M | -11.45M | -12.62M | -13.61M | -14.18M | ||||
| Net Cash Flow | -98.15M | -4.39M | 3.00M | 21.73M | -21.42M | -74.30M | -26.02M | -15.71M | 1.35M | -54.71M | 6.33M | -0.84M | -20.48M | 23.24M | 5.59M | 1.22M | -10.58M | -11.49M | 2.24M | -1.46M |